Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1093/cid/ciab647 http://scihub22266oqcxt.onion/10.1093/cid/ciab647 34293119!8406883!34293119     free     free     free       Clin+Infect+Dis 2022 ; 74 (7): 1271-1274 Nephropedia Template TP {{tp|p=34293119|t=2022. Effects of Treatment of Coronavirus Disease 2019 With Convalescent Plasma in 25 B-Cell-Depleted Patients |pdf=|usr=}}{{34293119}} gab.com Text Effects of Treatment of Coronavirus Disease 2019 With Convalescent Plasma in 25 B-Cell-Depleted Patients JO: Clin Infect Dis http://www.kidney.de/pget.php?&tw=1&pmid=34293119 #FOAvip Twenty-five B-cell-depleted patients (24 following anti-CD19/20 therapy) diagnosed with coronavirus disease 2019 had been symptomatic for a median of 26 days but remained antibody negative. All were treated with convalescent plasma with high neutralizing antibody titers. Twenty-one (84%) recovered, indicating the potential therapeutic effects of this therapy in this particular population. Twit Text FOAVip Effects of Treatment of Coronavirus Disease 2019 With Convalescent Plasma in 25 B-Cell-Depleted Patients ????Clin Infect Dis http://www.kidney.de/pget.php?&tw=1&pmid=34293119 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=34293119 #FOAvip English Wikipedia <ref>{{Cite pmid|34293119}}</ref> Effects of Treatment of Coronavirus Disease 2019 With Convalescent Plasma in 25 B-Cell-Depleted Patients #MMPMID34293119 Gharbharan A; GeurtsvanKessel CH; Jordans CCE; Blaauw M; van der Klift M; Hassing RJ; Smits-Zwinkels M; Meertens M; van den Hout EC; de Man AM; Hageman I; Bogers S; van der Schoot CE; Swaneveld F; Anas AA; Rokx C; Rijnders BJA Clin Infect Dis 2022[Apr]; 74 (7): 1271-1274 PMID34293119show ga Twenty-five B-cell-depleted patients (24 following anti-CD19/20 therapy) diagnosed with coronavirus disease 2019 had been symptomatic for a median of 26 days but remained antibody negative. All were treated with convalescent plasma with high neutralizing antibody titers. Twenty-one (84%) recovered, indicating the potential therapeutic effects of this therapy in this particular population. |*COVID-19/therapy[MESH] |Antibodies, Neutralizing/therapeutic use[MESH] |Antibodies, Viral[MESH] |COVID-19 Serotherapy[MESH] |Humans[MESH] |Immunization, Passive[MESH]Effects of Treatment of Coronavirus Disease 2019 With Convalescent Pla(epmc).pdf DeepDyve Pubget Overpricing